These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29529456)

  • 1. Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service.
    Nordeck CD; Welsh C; Schwartz RP; Mitchell SG; Cohen A; O'Grady KE; Gryczynski J
    Drug Alcohol Depend; 2018 May; 186():23-28. PubMed ID: 29529456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service.
    Nordeck CD; Welsh C; Schwartz RP; Mitchell SG; O'Grady KE; Gryczynski J
    Drug Alcohol Depend Rep; 2022 Mar; 2():100031. PubMed ID: 36845893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
    Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
    Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing Hospital Readmission for Patients With Comorbid Substance Use Disorder : A Randomized Trial.
    Gryczynski J; Nordeck CD; Welsh C; Mitchell SG; O'Grady KE; Schwartz RP
    Ann Intern Med; 2021 Jul; 174(7):899-909. PubMed ID: 33819055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which patients receive an addiction consult? A preliminary analysis of the INREACH (INpatient REadmission post-Addiction Consult Help) study.
    D'Amico MJ; Walley AY; Cheng DM; Forman LS; Regan D; Yurkovic A; Samet JH; Weinstein ZM
    J Subst Abuse Treat; 2019 Nov; 106():35-42. PubMed ID: 31540609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigation Services to Avoid Rehospitalization among Medical/Surgical Patients with Comorbid Substance Use Disorder: Rationale and Design of a Randomized Controlled Trial.
    Nordeck CD; Welsh C; Schwartz RP; Mitchell SG; O'Grady KE; Dunlap L; Zarkin G; Orme S; Gryczynski J
    J Psychiatr Brain Sci; 2020; 5(3):. PubMed ID: 36147996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis.
    Englander H; Dobbertin K; Lind BK; Nicolaidis C; Graven P; Dorfman C; Korthuis PT
    J Gen Intern Med; 2019 Dec; 34(12):2796-2803. PubMed ID: 31410816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.
    Ramakrishnan D; Sureshanand S; Pittman B; Radhakrishnan R
    J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 36044600
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in length of stay and discharge destination among patients with substance use disorders: The effect of Substance Use Intervention Team (SUIT) consultation service.
    Thompson HM; Faig W; VanKim NA; Sharma B; Afshar M; Karnik NS
    PLoS One; 2020; 15(10):e0239761. PubMed ID: 33035229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The substance use intervention team: A hospital-based intervention and outpatient clinic to improve care for patients with substance use disorders.
    Tran TH; Swoboda H; Perticone K; Ramsey E; Thompson H; Hill K; Karnik NS
    Am J Health Syst Pharm; 2021 Feb; 78(4):345-353. PubMed ID: 33386739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment.
    Trowbridge P; Weinstein ZM; Kerensky T; Roy P; Regan D; Samet JH; Walley AY
    J Subst Abuse Treat; 2017 Aug; 79():1-5. PubMed ID: 28673521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
    Winhusen T; Theobald J; Kaelber DC; Lewis D
    Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance Use Disorder Treatment Following Clinician-Initiated Discontinuation of Long-Term Opioid Therapy Resulting from an Aberrant Urine Drug Test.
    Nugent SM; Dobscha SK; Morasco BJ; Demidenko MI; Meath THA; Frank JW; Lovejoy TI
    J Gen Intern Med; 2017 Oct; 32(10):1076-1082. PubMed ID: 28600754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders.
    Tsai J; Gu X
    Addict Sci Clin Pract; 2019 Mar; 14(1):9. PubMed ID: 30836991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis.
    Priest KC; Lovejoy TI; Englander H; Shull S; McCarty D
    J Gen Intern Med; 2020 Aug; 35(8):2365-2374. PubMed ID: 32291723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters.
    Bahorik AL; Satre DD; Kline-Simon AH; Weisner CM; Young-Wolff KC; Campbell CI
    Subst Abus; 2018 Jan; 39(1):59-68. PubMed ID: 28723312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-Discharge Treatment Engagement Among Patients with an Opioid-Use Disorder.
    Naeger S; Mutter R; Ali MM; Mark T; Hughey L
    J Subst Abuse Treat; 2016 Oct; 69():64-71. PubMed ID: 27568512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.
    Hasin DS; Fink DS; Olfson M; Saxon AJ; Malte C; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Livne O; Mannes ZL; Sherman SE; Wall MM
    Drug Alcohol Depend; 2022 May; 234():109383. PubMed ID: 35279457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Retention in a Substance Use Disorder Telemedicine Clinic.
    Maxwell JF; Feldman SS; Li L
    South Med J; 2024 Jul; 117(7):374-378. PubMed ID: 38959966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.